Risk factors for the persistence of respiratory symptoms in childhood asthma
- PMID: 11345291
- DOI: 10.1016/S1081-1206(10)62494-5
Risk factors for the persistence of respiratory symptoms in childhood asthma
Abstract
Objective: To evaluate the parameters which could predict the persistence of respiratory symptoms in asthmatic children who have been treated with a considerably uniform therapy.
Methods: A retrospective review was performed on the records of 279 children with asthma. An end of study visit, results of spirometry and prick tests completed the data. The mean age at referral and at final visit was 6.2 +/- 3.7 years and 8.9 +/- 4.1 years, respectively; and the children were followed up for a mean of 3 +/- 1.2 years.
Results: Eighty-five of the 279 patients (30%) experienced no respiratory symptoms in the previous 12 months. There was no significant difference between those with and without current respiratory symptoms with respect to age, sex, age at onset of symptoms, duration of followup, age at referral, therapeutic choice, severity of asthma and duration of symptoms at referral. For subjects with current respiratory symptoms the initial serum total IgE level, and the percentage of RAST/prick test positivity was significantly higher than those without current respiratory symptoms (P = 0.0027, P = 0.011, respectively). Although the initial FEF 25%-75%, FEV1, and FEV1/FVC was significantly lower in those with current respiratory symptoms (P = 0.003; P = 0.005; and P = 0.04, respectively), there was no statistically significant difference between lung functions of the two groups at the end of followup. The persistence of respiratory symptoms was significantly predicted by initial FEF25%-75% and sensitivity to allergens (P = 0.03 and P = 0.04, respectively).
Conclusions: We concluded that the risk factors for the persistence of respiratory symptoms in our patient population have been low FEF25%-75% value and sensitivity to allergens at referral.
Similar articles
-
Are risk factors of childhood asthma predicting disease persistence in early adulthood different in the developing world?Allergy. 2006 Jul;61(7):869-77. doi: 10.1111/j.1398-9995.2006.01082.x. Allergy. 2006. PMID: 16792587
-
Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.Clin Respir J. 2008 Oct;2(4):247-8. doi: 10.1111/j.1752-699X.2008.00064.x. Clin Respir J. 2008. PMID: 20298343
-
[Extrinsic and intrinsic asthma from childhood to early adult age. A 10-year follow-up].Ugeskr Laeger. 1996 Jun 17;158(25):3617-21. Ugeskr Laeger. 1996. PMID: 8693622 Danish.
-
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.Pediatrics. 1995 Apr;95(4):500-5. Pediatrics. 1995. PMID: 7700748
-
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review.
Cited by
-
The efficacy of allergen immunotherapy with cat dander in reducing symptoms in clinical practice.Biomed Res Int. 2013;2013:324207. doi: 10.1155/2013/324207. Epub 2013 Jul 31. Biomed Res Int. 2013. PMID: 23984343 Free PMC article.
-
Predicting future asthma morbidity in preschool inner-city children.J Asthma. 2011 Oct;48(8):797-803. doi: 10.3109/02770903.2011.604887. Epub 2011 Aug 23. J Asthma. 2011. PMID: 21861602 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical